Abstract: This invention is directed to poly-hydroxylated monocyclic N-heterocyclic derivatives selected from the following formula:
wherein Z1, Z2, R1, R2, R3, R4, R5, R6, and R7 are defined herein. These compounds are useful as anti-coagulants.
Abstract: This invention is directed to poly-hydroxylated monocyclic N-heterocyclic derivatives selected from the following formulae:
wherein Z1, Z2, R1, R2, R3, R4, R5, R6, and R7 are defined herein. These compounds are useful as anti-coagulants.
Abstract: This invention is directed to poly-hydroxylated monocyclic N-heterocyclic derivatives selected from the following formulae:
wherein Z1, Z2, R1, R2, R3, R4, R5, R6, and R7 are defined herein. These compounds are useful as anti-coagulants.
Abstract: This invention is directed to benzamidine derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Type:
Grant
Filed:
August 7, 2001
Date of Patent:
November 12, 2002
Assignee:
Berlex Laboratories, Inc.
Inventors:
Brad O. Buckman, David D. Davey, William J. Guilford, Michael M. Morrissey, Howard P. Ng, Gary B. Phillips, Shung C. Wu, Wei Xu
Abstract: This invention is directed to benzamidine derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Type:
Grant
Filed:
August 8, 2001
Date of Patent:
October 15, 2002
Assignee:
Berlex Laboratories, Inc.
Inventors:
Brad O. Buckman, David D. Davey, William J. Guilford, Michael M. Morrissey, Howard P. Ng, Gary B. Phillips, Shung C. Wu, Wei Xu
Abstract: N-Heterocyclic derivatives of the formula (I):
are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing these compounds are also described herein.
Type:
Grant
Filed:
August 26, 1999
Date of Patent:
August 13, 2002
Assignees:
Berlex Laboratories, Inc., Pharmacopeia, Inc.
Inventors:
Damian O. Arnaiz, John J. Baldwin, David D. Davey, James J. Devlin, Roland Ellwood Dolle, III, Shawn David Erickson, Kirk McMillan, Michael M. Morrissey, Michael H. J. Ohlmeyer, Gonghua Pan, Vidyadhar Madhav Paradkar, John Parkinson, Gary B. Phillips, Bin Ye, Zuchun Zhao
Abstract: This invention is directed to compounds of formula (III):
wherein B, C, D, E, R1, R2 and R3 are disclosed herein. These components are disclosed as being useful as anti-coagulants.
Type:
Grant
Filed:
August 3, 2000
Date of Patent:
April 30, 2002
Assignee:
Berlex Laboratories, Inc.
Inventors:
Damian O. Arnaiz, Yuo-Ling Chou, Brian D. Griedel, Rushad E. Karanjawala, Monica J. Kochanny, Wheeseong Lee, Amy Mei Liang, Michael M. Morrissey, Gary B. Phillips, Karna Lyn Sacchi, Steven T. Sakata, Kenneth J. Shaw, R. Michael Snider, Shung C. Wu, Bin Ye, Zuchun Zhao
Abstract: This invention is directed to aryl and heterocyclyl substituted pyrimidine derivatives selected from the following formulae:
wherein Z1, Z2, R1, R2, R3, R4, R5 and R6 are defined herein. These compounds are useful as anti-coagulants.
Abstract: This invention is directed to benzamidine derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Type:
Grant
Filed:
December 8, 1999
Date of Patent:
February 26, 2002
Assignee:
Berlex Laboratories, Inc.
Inventors:
Brad O. Buckman, David D. Davey, William J. Guilford, Michael M. Morrissey, Howard P. Ng, Gary B. Phillips, Shung C. Wu, Wei Xu
Abstract: This invention is directed to benzenamine derivatives of formula (I):
wherein A, W, m, n, R1, R2, R3, R4, R5 and R6 are defined herein. These compounds are useful as anti-coagulants.
Type:
Grant
Filed:
July 24, 2000
Date of Patent:
February 26, 2002
Assignee:
Berlex Laboratories, Inc.
Inventors:
William J. Guilford, Steven T. Sakata, Kenneth J. Shaw, Shung Wu, Wei Xu, Zuchun Zhao
Abstract: This invention is directed to benzamidine derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Type:
Grant
Filed:
November 8, 1999
Date of Patent:
October 23, 2001
Assignee:
Berlex Laboratories, Inc.
Inventors:
Brad O. Buckman, David D. Davey, William J. Guilford, Michael M. Morrissey, Howard P. Ng, Gary B. Phillips, Shung C. Wu, Wei Xu
Abstract: This invention is directed to benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Type:
Grant
Filed:
November 12, 1999
Date of Patent:
July 24, 2001
Assignee:
Berlex Laboratories, Inc.
Inventors:
Monica Kochanny, Michael M. Morrissey, Howard P. Ng
Abstract: This invention is directed to poly-hydroxylated monocyclic N-heterocyclic derivatives selected from the following formulae:
wherein Z1, Z2, R1, R2, R3, R4, R5, R6, and R7 are defined herein. These compounds are useful as anti-coagulants.
Abstract: This invention is directed to benzamidine derivatives substituted by amino acid and hydroxy acid derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Type:
Grant
Filed:
September 9, 1999
Date of Patent:
June 5, 2001
Assignee:
Berlex Laboratories Inc.
Inventors:
Monica Kochanny, Raju Mohan, Michael M. Morrissey, Howard P. Ng, Weiya Yun
Abstract: This invention is directed to benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Type:
Grant
Filed:
November 12, 1999
Date of Patent:
May 15, 2001
Assignee:
Berlex Laboratories, Inc.
Inventors:
Monica Kochanny, Michael M. Morrissey, Howard P. Ng
Abstract: This invention is directed to monocyclic N-heterocyclics which are substituted by acyclic or cyclic thio derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Type:
Grant
Filed:
January 11, 2000
Date of Patent:
April 24, 2001
Assignee:
Berlex Laboratories, Inc.
Inventors:
Monica J. Kochanny, Michael M. Morrissey, Howard P. Ng
Abstract: This invention is directed to acyl piperazine derivatives of formula (Ia):
wherein R1a, R2, R3, R4, R5 and R6 are defined herein, which are useful as anti-inflammatory agents. This invention is also directed to other acyl piperazine derivatives, pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat inflammatory disorders in humans.
Type:
Grant
Filed:
June 9, 1998
Date of Patent:
March 27, 2001
Assignee:
Schering Aktiengesellschaft
Inventors:
John G. Bauman, Brad O. Buckman, Ameen F. Ghannam, Joseph E. Hesselgesser, Richard Horuk, Imadul Islam, Meina Liang, Karen B. May, Sean D. Monahan, Michael M. Morrissey, Howard P. Ng, Guo Ping Wei, Wei Xu, Wei Zheng
Abstract: This invention is directed to benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Type:
Grant
Filed:
November 12, 1999
Date of Patent:
January 23, 2001
Assignee:
Berlex Laboratories, Inc.
Inventors:
Monica Kochanny, Michael M. Morrissey, Howard P. Ng
Abstract: This invention is directed to monocyclic N-heterocyclics which are substituted by acyclic or cyclic thio derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Type:
Grant
Filed:
May 19, 1999
Date of Patent:
December 26, 2000
Assignee:
Berlex Laboratories, Inc.
Inventors:
Monica J. Kochanny, Michael M. Morrissey, Howard P. Ng
Abstract: This invention is directed to benzamidine derivatives substituted by amino acid and hydroxy acid derivatives which are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Type:
Grant
Filed:
September 9, 1999
Date of Patent:
December 26, 2000
Assignee:
Berlex Laboratories, Inc.
Inventors:
Monica Kochanny, Raju Mohan, Michael M. Morrissey, Howard P. Ng, Weiya Yun